UCB 
By Participation on January 23, 2012 (according to Article 6 of the law of May 2, 2007 on the disclosure of large shareholdings).
Brussels (Belgium), 27 January 2012 - 18:00 PM CET - regulated information - Wellington Management Company, LLP having its registered offices at 75 State Street, Boston, MA 02109, United States of America, sold a number of shares with voting rights on January 23, 2012 crossing down the threshold of 3% of UCB's capital, the lowest statutory threshold for notification (5 505 950 shares on a total of 183,365,052 or 3%).
Notes to the editor
About UCB
) is a global biopharmaceutical company focused on the
discovery and development of innovative medicines and
solutions to transform the lives of people living with
severe diseases of the immune system or of the central
nervous system. With more than 8 500 people in about 40
countries, the company generated revenue of EUR 3.2 billion
in 2010. UCB is listed on Euronext Brussels (symbol: UCB).
| distribué par | Ce noodl a été diffusé par UCB SA et initialement mise en ligne sur le site http://www.ucb-group.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-27 19:06:15 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
